0000950170-24-033845.txt : 20240319
0000950170-24-033845.hdr.sgml : 20240319
20240319195815
ACCESSION NUMBER: 0000950170-24-033845
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tada Hiroomi
CENTRAL INDEX KEY: 0001880593
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 24765852
MAIL ADDRESS:
STREET 1: C/O TYRA BIOSCIENCES, INC
STREET 2: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831476348
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
ownership.xml
4
X0508
4
2024-03-15
0001863127
Tyra Biosciences, Inc.
TYRA
0001880593
Tada Hiroomi
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
false
true
false
false
Chief Medical Officer
false
Common Stock
2024-03-15
4
A
false
1968
6.5790
A
86435
D
These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
/s/ Ali D. Fawaz, Attorney-in-Fact
2024-03-19